v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1

Oncogene

Volumn 22, Issue 16, 2003, Pages 2383-2395

  Maclaren, A ^a   Clark, W ^a   Black, E J ^a   Gregory, D ^c   Fujii, H ^d   Gillespie, D A F ^b  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Jun; P21CIP1; P53

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; MUTANT PROTEIN; ONCOPROTEIN; PHOSPHOTRANSFERASE; PROTEIN P21; PROTEIN P53; PROTEIN V JUN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL TRANSFORMATION; CHICK EMBRYO; DEREGULATION; FIBROBLAST; GENE REPRESSION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SERUM; STIMULATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CDC2-CDC28 KINASES; CHICK EMBRYO; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DOWN-REGULATION; G1 PHASE; GENE EXPRESSION REGULATION; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEIN P65(GAG-JUN); PROTEIN-SERINE-THREONINE KINASES; S PHASE; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; EUKARYOTA;

EID: 0037655057     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206329     Document Type: Article

References (41)

1. Bader AG, Schneider ML, Bister K and Hartl M. (2001). Oncogene, 20, 7524-7535.
2. Blalock WL, Pearce M, Steelman LS, Franklin RA, McCarthy SA, Cherwinski H, McMahon M and McCubrey JA. (2000). Oncogene, 19, 526-536.
3. Chen BK and Chang WC. (2000). Proc. Natl. Acad. Sci. USA, 97, 10406-10411.
4. Claassen GF and Hann SR. (2000). Proc. Natl. Acad. Sci. USA, 97, 9498-9503.
5. Clark W, Black EJ, MacLaren A, Kruse U, LaThangue N, Vogt PK and Gillespie DA. (2000). Mol. Cell. Biol., 20, 2529-2542.
6. Clark W and Gillespie DA. (1997). Cell Growth Differ., 8, 371-380.
7. Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN and Golub TR. (2000). Proc. Natl. Acad. Sci. USA, 97, 3260-3265.
8. Cox LS. (1997). J. Pathol., 183, 134-140.
9. Datto MB, Yu Y and Wang XF. (1995). J. Biol. Chem., 270, 28623-28628.
10. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
11. Erhardt JA and Pittman RN. (1998). Oncogene, 16, 443-451.
12. Fu S, Bottoli I, Goller M and Vogt PK. (1999). Proc. Natl. Acad. Sci. USA, 96, 5716-5721.
13. Fu SL, Waha A and Vogt PK. (2000). Oncogene, 19, 3537-3545.
14. Gao M, Morgan I and Vogt PK. (1996). Cancer Res., 56, 4229-4235.
15. Gartel AL and Tyner AL. (1999). Exp. Cell Res., 246, 280-289.
16. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F and Tyner AL. (2001). Proc. Natl. Acad. Sci. USA, 98, 4510-4515.
17. Gervais JL, Seth P and Zhang H. (1998). J. Biol. Chem., 273, 19207-19212.
18. Givol I, Givol D, Rulong S, Resau J, Tsarfaty I and Hughes SH. (1995). Oncogene, 11, 2609-2618.
19. Haapajarvi T, Kivinen L, Heiskanen A, des Bordes C, Datto MB, Wang XF and Laiho M. (1999). Exp. Cell Res., 248, 272-279.
20. Hadman M, Gabos L, Loo M, Sehgal A and Bos TJ. (1996). Oncogene, 12, 135-142.
21. Hall M and Peters G. (1996). Adv. Cancer Res., 68, 67-108.
22. Hartl M and Bister K. (1995). Proc. Natl. Acad. Sci. USA, 92, 11731-11735.
23. Hartwell LH and Kastan MB. (1994). Science, 266, 1821-1828.
24. Juven T, Barak Y, Zauberman A, George DL and Oren M. (1993). Oncogene, 8, 3411-3416.
25. Kardassis D, Papakosta P, Pardali K and Moustakas A. (1999). J. Biol. Chem., 274, 29572-29581.
26. Kilbey A, Black EJ, Unlu M and Gillespie DA. (1996). Oncogene, 12, 2409-2418.
27. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A and Harlow E. (1997). Genes Dev., 11, 847-862.
28. MacLaren A, Clark W and Gillespie DA. (2000). Oncogene, 19, 5906-5918.
29. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T. (1995). Genes Dev., 9, 935-944.
30. Maki Y, Bos TJ, Davis C, Starbuck M and Vogt PK. (1987). Proc. Natl. Acad. Sci. USA, 84, 2848-2852.
31. Mitchell KO and El-Deiry WS. (1999). Cell Growth Differ., 10, 223-230.
32. Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M and McCormick F. (2000). Cell, 103, 321-330.
33. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D and Goldberg AL. (1994). Cell, 78, 761-771.
34. Schreiber M, Kolbus A, Piu F, Szabowski A, U Mh-S, Tian J, Karin M, Angel P and Wagner EF. (1999). Genes Dev., 13, 607-619.
35. Shaulian E, Schreiber M, Piu F, Beeche M, Wagner EF and Karin M. (2000). Cell, 103, 897-907.
36. Tsao YP, Li LY, Tsai TC and Chen SL. (1996). J. Virol., 70, 7535-7539.
37. Vogt PK. (2001). Oncogene, 20, 2365-2377.
38. Vogt PK and Bos TJ. (1990). Adv. Cancer Res., 55, 1-35.
39. Waldman T, Lengauer C, Kinzler KW and Vogelstein B. (1996). Nature, 381, 713-716.
40. Wang CH, Tsao YP, Chen HJ, Chen HL, Wang HW and Chen SL. (2000). Biochem. Biophys. Res. Commun., 270, 303-310.
41. Wu RC and Schonthal AH. (1997). J. Biol. Chem., 272, 29091-29098.